Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

MEDRELEAF CORP
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by saveyourselfnowon Jun 24, 2018 11:10am
161 Views
Post# 28220313

APHRIA PRICE SURGE ALERT!

APHRIA PRICE SURGE ALERT!
https://www.tradingview.com/symbols/TSX-APH/

you can see clearly now - Molson's pact out of the bag and will be proven Monday when volume goes parabolic.

remember the ACB / CMED and ACB / LEAF leaks propelled both CMED and LEAF to new highs.

And the leaks came true!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities